Legend Biotech Corp - COMMON STOCK (LEGN)

Q2 2022 13F Holders as of 6/30/2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
367M
Number of holders
145
Total 13F shares, excl. options
52.4M
Shares change
+1.64M
Total reported value, excl. options
$2.88B
Value change
+$117M
Put/Call ratio
0.42
Number of buys
79
Number of sells
-70
Price
$55.00

Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q2 2022

183 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q2 2022.
Legend Biotech Corp - COMMON STOCK (LEGN) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 52.4M shares of 367M outstanding shares and own 14.27% of the company stock.
Largest 10 shareholders include FMR LLC (6.66M shares), HHLR ADVISORS, LTD. (4.44M shares), BlackRock Inc. (3.15M shares), Capital International Investors (3.04M shares), WELLINGTON MANAGEMENT GROUP LLP (2.61M shares), Capital World Investors (2.39M shares), FEDERATED HERMES, INC. (2.11M shares), Artisan Partners Limited Partnership (1.71M shares), JOHNSON & JOHNSON (1.63M shares), and ALLIANCEBERNSTEIN L.P. (1.47M shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.